A Phase Ib/Ii Trial Of Ak104 (Pd-1/Ctla-4 Bispecific Antibody) In Combination With Anlotinib In Advanced NsclcL. Wu, B. Chen,W. Yao,X. Li,Z. Xiao,H. Liu, Y. Kong,L. Liu,Y. Xu,Q. Wang, J. Li, F. Xu, L. Xu,K. Li,W. Song,B. Li,Z. M. Wang, Y. XiaANNALS OF ONCOLOGY(2021)引用 7|浏览7暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要